Skip to main content

Advertisement

SpringerLink
Log in

Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146

  • Preclinical study
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Most assays to detect circulating tumor cells (CTCs) rely on EpCAM expression on tumor cells. Recently, our group reported that in contrast to other molecular breast cancer subtypes, “normal-like” cell lines lack EpCAM expression and are thus missed when CTCs are captured with EpCAM-based technology [J Natl Cancer Inst 101(1):61–66, 2009]. Here, the use of CD146 is introduced to detect EpCAM-negative CTCs, thereby improving CTC detection. CD146 and EpCAM expression were assessed in our panel of 41 breast cancer cell lines. Cells from 14 cell lines, 9 of which normal-like, were spiked into healthy donor blood. Using CellSearch™ technology, 7.5 ml whole blood was enriched for CTCs by adding ferrofluids loaded with antibodies against EpCAM and/or CD146 followed by staining for Cytokeratin and DAPI. Hematopoietic cells and circulating endothelial cells (CECs) were counterstained with CD45 and CD34, respectively. A similar approach was applied for blood samples of 20 advanced breast cancer patients. Eight of 9 normal-like breast cancer cell lines lacked EpCAM expression but did express CD146. Five of these 8 could be adequately recovered by anti-CD146 ferrofluids. Of 20 advanced breast cancer patients whose CTCs were enumerated with anti-EpCAM and anti-CD146 ferrofluids, 9 had CD146+ CTCs. Cells from breast cancer cell lines that lack EpCAM expression frequently express CD146 and can be recovered by anti-CD146 ferrofluids. CD146+ CTCs are present in the peripheral blood of breast cancer patients with advanced disease. Combined use of anti-CD146 and anti-EpCAM is likely to improve CTC detection in breast cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Sleijfer S, Gratama JW, Sieuwerts AM, Kraan J, Martens JW, Foekens JA (2007) Circulating tumour cell detection on its way to routine diagnostic implementation? Eur J Cancer 43(18):2645–2650

    PubMed  CAS  Google Scholar 

  2. Mostert B, Sleijfer S, Foekens JA, Gratama JW (2009) Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer. Cancer Treat Rev 35(5):463–474

    Article  PubMed  CAS  Google Scholar 

  3. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW et al (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8):781–791

    Article  PubMed  CAS  Google Scholar 

  4. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC et al (2005) Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23(7):1420–1430

    Article  PubMed  Google Scholar 

  5. HD SmerageJB (2008) The prognostic implications of circulating tumor cells in patients with breast cancer. Cancer Invest 26(2):109–114

    Article  Google Scholar 

  6. Rack BK, Schindlbeck C, Schneeweiss A, Hilfrich J, Lorenz R, Beckmann MW, Pantel K, Lichtenegger W, Sommer HL, Janni WL (2008) Prognostic relevance of circulating tumor cells (CTCs) in peripheral blood of breast cancer patients before and after adjuvant chemotherapy: the German SUCCESS-Trial. J Clin Oncol 26 (May 20 suppl: abstr 503)

  7. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA et al (2000) Molecular portraits of human breast tumours. Nature 406(6797):747–752

    Article  PubMed  CAS  Google Scholar 

  8. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Schutte M, Martens JW, Gratama JW, Sleijfer S, Foekens JA (2009) Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 101(1):61–66

    PubMed  CAS  Google Scholar 

  9. Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JG, Foekens JA, Martens JW (2008) Subtypes of breast cancer show preferential site of relapse. Cancer Res 68(9):3108–3114

    Article  PubMed  CAS  Google Scholar 

  10. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Smid M, Timmermans M, Mostert B, Schutte M, Martens JW et al (2009) Response: Re: anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 101(12):896–897

    Article  Google Scholar 

  11. Spizzo G, Went P, Dirnhofer S, Obrist P, Simon R, Spichtin H, Maurer R, Metzger U, von Castelberg B, Bart R et al (2004) High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat 86(3):207–213

    Article  PubMed  CAS  Google Scholar 

  12. Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C (2009) CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines. Breast Cancer Res 11(1):1

    Article  Google Scholar 

  13. Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, Merajver SD, Ethier SP, Schutte M (2006) BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res 66(1):41–45

    Article  PubMed  CAS  Google Scholar 

  14. Hollestelle A, Nagel JH, Smid M, Lam S, Elstrodt F, Wasielewski M, Ng SS, French PJ, Peeters JK, Rozendaal MJ et al (2009) Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat (Epub ahead of print)

  15. Strijbos MH, Gratama JW, Kraan J, Lamers CH, den Bakker MA, Sleijfer S (2008) Circulating endothelial cells in oncology: pitfalls and promises. Br J Cancer 98(11):1731–1735

    Article  PubMed  CAS  Google Scholar 

  16. Brakenhoff RH, Stroomer JG, ten Brink C, de Bree R, Weima SM, Snow GB, van Dongen GA (1999) Sensitive detection of squamous cells in bone marrow and blood of head and neck cancer patients by E48 reverse transcriptase-polymerase chain reaction. Clin Cancer Res 5(4):725–732

    PubMed  CAS  Google Scholar 

  17. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, Greaves MF (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75(12):2417–2426

    PubMed  CAS  Google Scholar 

  18. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M et al (2000) Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 24(3):227–235

    Article  PubMed  CAS  Google Scholar 

  19. Rae JM, Creighton CJ, Meck JM, Haddad BR, Johnson MD (2007) MDA-MB-435 cells are derived from M14 melanoma cells–a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res Treat 104(1):13–19

    Article  PubMed  Google Scholar 

  20. Chambers AF (2009) MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 69(13):5292–5293

    Article  PubMed  CAS  Google Scholar 

  21. Rowand JL, Martin G, Doyle GV, Miller MC, Pierce MS, Connelly MC, Rao C, Terstappen LW (2007) Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas. Cytometry A 71(2):105–113

    PubMed  Google Scholar 

  22. Pickl WF, Majdic O, Fischer GF, Petzelbauer P, Fae I, Waclavicek M, Stockl J, Scheinecker C, Vidicki T, Aschauer H et al (1997) MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol 158(5):2107–2115

    PubMed  CAS  Google Scholar 

  23. Smirnov DA, Foulk BW, Doyle GV, Connelly MC, Terstappen LW, O’Hara SM (2006) Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas. Cancer Res 66(6):2918–2922

    Article  PubMed  CAS  Google Scholar 

  24. SAGE anatomic viewer: KRT18 expression in vascular tissue. http://cgap.nci.nih.gov/SAGE/AnatomicViewer

  25. Hayes DF, Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Miller MC, Matera J, Allard WJ, Doyle GV, Terstappen LW (2006) Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 12(14 Pt 1):4218–4224

    Article  PubMed  CAS  Google Scholar 

  26. Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LW et al (2006) Circulating tumor cells versus imaging–predicting overall survival in metastatic breast cancer. Clin Cancer Res 12(21):6403–6409

    Article  PubMed  CAS  Google Scholar 

  27. Pierga JY, Bidard FC, Mathiot C, Brain E, Delaloge S, Giachetti S, de Cremoux P, Salmon R, Vincent-Salomon A, Marty M (2008) Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial. Clin Cancer Res 14(21):7004–7010

    Article  PubMed  CAS  Google Scholar 

  28. Bardin N, George F, Mutin M, Brisson C, Horschowski N, Frances V, Lesaule G, Sampol J (1996) S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue antigens 48(5):531–539

    Article  PubMed  CAS  Google Scholar 

  29. Lehmann JM, Riethmuller G, Johnson JP (1989) MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 86(24):9891–9895

    Google Scholar 

  30. Elshal MF, Khan SS, Raghavachari N, Takahashi Y, Barb J, Bailey JJ, Munson PJ, Solomon MA, Danner RL, McCoy JP Jr (2007) A unique population of effector memory lymphocytes identified by CD146 having a distinct immunophenotypic and genomic profile. BMC Immunol 8:29

    Article  PubMed  Google Scholar 

  31. Despoix N, Walzer T, Jouve N, Blot-Chabaud M, Bardin N, Paul P, Lyonnet L, Vivier E, Dignat-George F, Vely F (2008) Mouse CD146/MCAM is a marker of natural killer cell maturation. Eur J Immunol 38(10):2855–2864

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Antoinette Hollestelle and Anita Trapman for their precious help in providing the immunohistochemistry data. This study was in part financially supported by the Netherlands Genomic Initiative (NGI)/Netherlands Organization for Scientific Research (NWO).

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Daniel den Hoed Cancer Center and Laboratory of Translational Tumor Immunology, Erasmus MC, Groene Hilledijk 301, 3075 EA, Rotterdam, The Netherlands

    Bianca Mostert, Jaco Kraan, Petra van der Spoel, Jan-Willem Gratama & Stefan Sleijfer

  2. Department of Medical Oncology, Josephine Nefkens Institute and Cancer Genomics Center, Erasmus MC, Rotterdam, The Netherlands

    Bianca Mostert, Joan Bolt-de Vries, Anieta M. Sieuwerts, Annemieke M. Timmermans, Renée Foekens, John W. M. Martens, John A. Foekens & Stefan Sleijfer

  3. Department of Medical Oncology, Josephine Nefkens Institute and Laboratory of Tumor Biology and Pharmacogenomics, Erasmus MC, Rotterdam, The Netherlands

    Mieke Schutte

Authors
  1. Bianca Mostert
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jaco Kraan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joan Bolt-de Vries
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Petra van der Spoel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Anieta M. Sieuwerts
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mieke Schutte
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Annemieke M. Timmermans
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Renée Foekens
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. John W. M. Martens
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jan-Willem Gratama
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. John A. Foekens
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Stefan Sleijfer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bianca Mostert.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mostert, B., Kraan, J., Bolt-de Vries, J. et al. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146. Breast Cancer Res Treat 127, 33–41 (2011). https://doi.org/10.1007/s10549-010-0879-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-010-0879-y

Keywords

Search

Navigation